Viewing Study NCT00640159


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2026-03-08 @ 5:55 AM
Study NCT ID: NCT00640159
Status: COMPLETED
Last Update Posted: 2023-08-09
First Post: 2008-03-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Selegiline to Zelapar Switch Study in Parkinson Disease Patients
Sponsor: Baylor College of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Parkinson's disease View
None selegiline to Zelapar switch View
None orally disintegrating formulation View